Kadri AN, et al. - Using the Nationwide Readmission Database (2013 to 2014), researchers investigated if higher readmission rates or increased mortality could be seen in relation to coexistent Tricuspid regurgitation (TR) in patients with heart failure (HF) and mitral valve disease (MVD). This study included 221,127 admissions with HF and MVD, excluding cases without MVD, patients <18 years old, those suffering rheumatic heart disease and infective endocarditis, as well as those who were discharged in December, hospital transfers, and cases where follow-up or outcomes were missing. The study sample had a median age of 79 years (IQR, 67 to 87), with 55% being female. During hospitalization, death of 2.7% was reported and 20.3% was estimated as the 30-day readmission rate. The presence of concomitant TR was reported in approximately 1/3 (n = 78,356, 35%). According to the findings, no worse short-term outcomes in terms of inpatient hospital mortality and 30-day readmission rates were reported in relation to concomitant TR in patients with HF and MVD.